본문 바로가기 주메뉴 바로가기 푸터 바로가기

연구논문

결핵연구원의 연구논문을 보실 수 있습니다.

연구논문

DOI 내의 링크를 누르면 논문을 확인할 수 있습니다.

연구논문 목록
번호 제목 년도 저널 DOI
21
Dimethyl itaconate is effective in host-directed antimicrobial responses against mycobacterial infections through multifaceted innate immune pathways
년도2023 저널Cell & Bioscience https://link.springer.com/article/10.1186/s13578-023-00992-x
20
Differential Immune Responses and Underlying Mechanisms of Metabolic Reprogramming in Smooth and Rough Variants of Mycobacterium peregrinum Infections
년도2023 저널Pathogens https://www.mdpi.com/2076-0817/12/12/1446
19
Genetic stability of Mycobacterium abscessus during antibiotic treatment
년도2023 저널J Glob Antimicrob Resist https://www.sciencedirect.com/science/article/pii/S2213716523002114
18
Performance Evaluation of the BACTEC MGIT 960 System for Rifampin Drug-Susceptibility Testing of Myconcacterium tuberculosisUsing the Current WHO Critical Concentration
년도2023 저널Journal of Clinical Microbiology https://journals.asm.org/doi/full/10.1128/jcm.01086-22
17
Prevalence and associated factors of diabetes mellitus among patients with tuberculosis in South Korea from 2011 to 2018: a nationwide cohort study
년도2023 저널BMJ Open https://bmjopen.bmj.com/content/13/3/e069642.abstract
16
Arginine-mediated gut microbiome remodeling promotes host pulmonary immune defense against nontuberculous mycobacterial infection
년도2022 저널Gut Microbes https://pubmed.ncbi.nlm.nih.gov/35579969/
15
Evaluation of Five User-Friendly Whole Genome Sequencing Software for Mycobacterium tuberculosis in Clinical Application
년도2022 저널J Korean Med Sci https://jkms.org/DOIx.php?id=10.3346/jkms.2022.37.e328
14
9 month of delamanid, linezolid, levofloxacin, and pyrazinamide versus conventional therpy for treatment of fluoroquinolone-sensitive multidrug-resistant tuberculosis (MDR-END): a multicentre, randomised, open-label phase 2/3 non-inferiority trial in Sout
년도2022 저널The Lancet https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(22)01883-9/abstract
13
Bedaquiline Drug Resistance Emergence Assessment in Multidrug-Resistant Tuberculosis (MDR-TB): a 5-Year Prospective In Vitro Surveillance Study of Bedaquiline and Other Second-Line Drug Susceptibility Testing in MDR-TB Isolates
년도2022 저널Journal of Clinical Microbiology https://journals.asm.org/doi/full/10.1128/jcm.02919-20
12
Sex differences in the impact of diabetes mellitus on tuberculosis recurrence: A retrospective national cohort study
년도2022 저널Int J Infect Dis https://www.sciencedirect.com/science/article/pii/S1201971222006282
11
Population Pharmacokinetics of Levofloxacin and Moxifloxacin, and the Probability of Target Attainment in Ethiopian Patietns with Multidrug-Resistant Tuberculosis
년도2022 저널Infection and Drug Resistance http://dx.doi.org/10.2147/idr.s389442
10
Risk factors associated with tuberculosis recurrence in South Korea determined using a nationwide cohort study.
년도2022 저널PLOS ONE https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0268290
9
Arginine-mediated gut microbiome remodeling promotes host pulmonary immune defense against nontuberculous mycobacterial infection
년도2022 저널Gut Microbes https://pubmed.ncbi.nlm.nih.gov/35579969/
8
Cohort Profile: Korean Tuberculosis and Post-Tuberculosis Cohort Constructed by Linking Korean National Tuberculosis Surveillance System and National Health Information Database.
년도2022 저널JPMPH(Journal of Preventive https://pubmed.ncbi.nlm.nih.gov/35677999/
7
Aconitate Decarboxylase 1 Deficiency Exacerbates Mouse Colitis Induced by Dextran Sodium Sulfate
년도2022 저널Int J Mol Sci https://www.mdpi.com/1422-0067/23/8/4392
게시물을 검색합니다.

검색